Stevin Zorn, PhD, discusses research into exploitation of a single mechanism of action for possible treatment and prevention of Alzheimer disease, and a possible shift of focus towards experimenting with...
What have practitioners learned from the first wave of COVID-19 that can be applied to the treatment of patients with autoimmune rheumatic conditions during this next wave? Michael George, MD, discusses in...
In this video, Karen Onel, MD, explains why the most recent JIA recommendations are needed as well as what new areas they address that had not been included in past guidelines.
